1. Downregulation of Lymphoid enhancer-binding factor 1 (LEF-1) expression (by immunohistochemistry and/ flow cytometry) in chronic Lymphocytic Leukemia with atypical immunophenotypic and cytologic features. Soliman, D. S., Al-Kuwari, E., Siveen, K. S., Al-Abdulla, R., Chandra, P., Yassin, M., Nashwan, A., Hilmi, F. A., Taha, R. Y., Nawaz, Z., El-Omri, H., Mateo, J. M., & Al-Sabbagh, A. (2021). International journal of laboratory hematology43(3), 515–525. https://doi.org/10.1111/ijlh.13420

  2. Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting. Abu-Raddad, L. J., Chemaitelly, H., Malek, J. A., Ahmed, A. A., Mohamoud, Y. A., Younuskunju, S., Ayoub, H. H., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Coyle, P., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Yassine, H. M., Al Kuwari, M. G., Al Romaihi, H. E., … Bertollini, R. (2021). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America73(7), e1830–e1840. https://doi.org/10.1093/cid/ciaa1846

  3. Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months. Abu-Raddad, L. J., Chemaitelly, H., Malek, J. A., Ahmed, A. A., Mohamoud, Y. A., Younuskunju, S., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Coyle, P., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Yassine, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Al-Thani, M. H., … Bertollini, R. (2021). Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases88, 104684. https://doi.org/10.1016/j.meegid.2020.104684

  4. Ayoub, H. H., Chemaitelly, H., Seedat, S., Makhoul, M., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Coyle, P., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Rahim, H. A., Yassine, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Al-Thani, M. H., Bertollini, R., & Abu Raddad, L. J. (2021). Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19. Ayoub, H. H., Chemaitelly, H., Seedat, S., Makhoul, M., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Coyle, P., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Rahim, H. A., Yassine, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Al-Thani, M. H., Bertollini, R., & Abu Raddad, L. J. (2021). Journal of global health11, 05005. https://doi.org/10.7189/jogh.11.05005

  5. Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic. Abu-Raddad, L. J., Chemaitelly, H., Ayoub, H. H., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Coyle, P., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Owen, R. C., Rahim, H. F. A., Al Abdulla, S. A., Al Kuwari, M. G., Kandy, M. C., Saeb, H., Ahmed, S. N. N., Al Romaihi, H. E., Bansal, D., … Bertollini, R. (2021). Scientific reports11(1), 6233. https://doi.org/10.1038/s41598-021-85428-7

  6. Coyle, P. V., Chemaitelly, H., Ben Hadj Kacem, M. A., Abdulla Al Molawi, N. H., El Kahlout, R. A., Gilliani, I., Younes, N., Al Anssari, G. A. A. A., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G. K., Yassine, H. M., Al Kuwari, M. G., … Abu-Raddad, L. J. (2021). SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals. Coyle, P. V., Chemaitelly, H., Ben Hadj Kacem, M. A., Abdulla Al Molawi, N. H., El Kahlout, R. A., Gilliani, I., Younes, N., Al Anssari, G. A. A. A., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G. K., Yassine, H. M., Al Kuwari, M. G., … Abu-Raddad, L. J. (2021). iScience24(6), 102646. https://doi.org/10.1016/j.isci.2021.102646

  7. Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population. Nasrallah, G.K., Dargham, S.R., Shurrab, F. et al.Sci Rep 11, 11837 (2021). https://doi.org/10.1038/s41598-021-91235-

  8. Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveal minor discrepancies in a high-incidence population. Nasrallah GK, Dargham SR, Shurrab F, Al-Sadeq DW, Al-Jighefee H, Chemaitelly H, Al Kanaani Z, Al Khal A, Al Kuwari E, Coyle P, Jeremijenko A, KaleeckalAH, Latif AN, Shaik RM, Rahim HFA, Yassine HM, Al Kuwari MG, Qotba H, Al Romaihi, HE, Tang P, Bertollini R, Al-Thani MH, Althani AA, Abu-Raddad LJ Sci Rep. 2021 Jun 4;11(1):11837. https://doi.org/10.1038/s41598-021-91235-x

  9. Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses. Abu-Raddad, L. J., Chemaitelly, H., Yassine, H. M., Benslimane, F. M., Al Khatib, H. A., Tang, P., Malek, J. A., Coyle, P., Ayoub, H. H., Al Kanaani, Z., Al Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G. K., Al Kuwari, M. G., Al Romaihi, H. E., Al-Thani, M. H., … Bertollini, R. (2021). Journal of travel medicine28(7), taab083. https://doi.org/10.1093/jtm/taab083

  10. SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy. Abu-Raddad, L. J., Chemaitelly, H., Coyle, P., Malek, J. A., Ahmed, A. A., Mohamoud, Y. A., Younuskunju, S., Ayoub, H. H., Al Kanaani, Z., Al Kuwari, E., Butt, A. A., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G. K., Yassine, H. M., Al Kuwari, M. G., Al Romaihi, H. E., … Bertollini, R. (2021). EClinicalMedicine35, 100861. https://doi.org/10.1016/j.eclinm.2021.100861

  11. Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar. Jeremijenko, A., Chemaitelly, H., Ayoub, H. H., Alishaq, M., Abou-Samra, A. B., Al Ajmi, J. A. A. A., Al Ansari, N. A. A., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Al-Mohammed, A., Al Molawi, N. H. A., Al Naomi, H. M., Butt, A. A., Coyle, P., El Kahlout, R. A., Gillani, I., Kaleeckal, A. H., Masoodi, N. A., Thomas, A. G., … Abu-Raddad, L. J. (2021). Emerging infectious diseases27(5), 1343–1352. https://doi.org/10.3201/eid2705.204365

  12. mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar. Chemaitelly, H., Yassine, H. M., Benslimane, F. M., Al Khatib, H. A., Tang, P., Hasan, M. R., Malek, J. A., Coyle, P., Ayoub, H. H., Al Kanaani, Z., Al Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G. K., Al Kuwari, M. G., Al Romaihi, H. E., Al-Thani, M. H., … Abu-Raddad, L. J. (2021). Nature medicine27(9), 1614–1621. https://doi.org/10.1038/s41591-021-01446-y

  13. One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar. Benslimane, F. M., Al Khatib, H. A., Al-Jamal, O., Albatesh, D., Boughattas, S., Ahmed, A. A., Bensaad, M., Younuskunju, S., Mohamoud, Y. A., Al Badr, M., Mohamed, A. A., El-Kahlout, R. A., Al-Hamad, T., Elgakhlab, D., Al-Kuwari, F. H., Saad, C., Jeremijenko, A., Al-Khal, A., Al-Maslamani, M. A., Bertollini, R., … Yassine, H. M. (2021). Frontiers in cellular and infection microbiology11, 768883. https://doi.org/10.3389/fcimb.2021.768883

  14. Leukocyte chemotactic factor 2-related amyloidosis presenting with severe jaundice and hepatic encephalopathy. Almasri H, Razok A, Badi A, Almohannadi M, Lutf A, Petkar M, Elzouki A. Clin Case Rep. 2021 Dec 5;9(12):e05185. doi: 10.1002/ccr3.5185. eCollection 2021 Dec. PMID: 34917382

  15. Late Cystic Metastasis of an Ovarian Granulosa Cell Tumor to the Liver. Aleter A, Mahajan PS, Petkar MA, Abdulmajeed HA, Khalaf H, Elmoghazy W, Elaffandi A. Cureus. 2021 Sep 17;13(9):e18051. doi: 10.7759/cureus.18051. eCollection 2021 Sep. PMID: 34671531

  16. Glomus tumours of the upper limb and hand. A clinicopathological review of cases over two decades. Jabir S, Rodrigo T, Petkar M, Iwuagwu F. J Hand Surg Eur Vol. 2022 Apr;47(4):419-420. doi: 10.1177/17531934211049632. Epub 2021 Oct 14. PMID: 34647499

  17. Metastatic angiosarcoma of the scalp presented as posttraumatic subgaleal hematoma: The many faces of a diagnostic challenge. Aker L, Petkar MA, Quazi SJ, Adam RI. Radiol Case Rep. 2021 Jul 23;16(9):2812-2816. doi: 10.1016/j.radcr.2021.06.083. eCollection 2021 Sep. PMID: 34354789

  18. SARS-CoV-2 and guttate psoriasis: A case report and review of literature. Ali E, Mohamed A, Abuodeh J, Albuni MK, Al-Mannai N, Salameh S, Petkar M, Habas E. Clin Case Rep. 2021 Jul 16;9(7):e04568. doi: 10.1002/ccr3.4568. eCollection 2021 Jul. PMID: 34295501

  19. First case of huge classic papillary thyroid cancer rupturing spontaneously leading to ischemic necrosis, perforation and inflammation of overlying skin: Case report and review of the literature. Abusabeib A, El Ansari W, Al Hassan MS, Petkar M, Mohamed S. Int J Surg Case Rep. 2021 Aug;85:106136. doi: 10.1016/j.ijscr.2021.106136. Epub 2021 Jun 29. PMID: 34274758

  20. Glottic Malignant Fibrous Histiocytoma: A Case Report and Literature Review. Aljariri AA, Alsaleh AR, Al-Enazi HA, Haider HA, Petkar M, Rahman W, Nashwan AJ. Case Rep Oncol. 2021 Mar 31;14(1):641-646. doi: 10.1159/000514977. eCollection 2021 Jan-Apr. PMID: 33976647

  21. Nasal-alar invasive cutaneous aspergillosis in a patient with anaplastic astrocytoma: A case report. Aljariri AA, Shaikh A, Nashwan AJ, Petkar MA, Ganesan S. Clin Case Rep. 2021 Mar 8;9(4):2295-2299. doi: 10.1002/ccr3.4018. eCollection 2021 Apr. PMID: 33936682

  22. Hepatitis E Viral Association with Autoimmune Hepatitis: A Viral Trigger or Cross-Reactivity. Elfert KA, Qasim HM, Faisal MM, Elghazali A, Siddiqui MYA, Petkar M, Sadik N. Case Rep Gastroenterol. 2021 Feb 3;15(1):115-122. doi: 10.1159/000509494. eCollection 2021 Jan-Apr. PMID: 33708058

  23. Ancient foe spectra: Case series of Mycobacterium tuberculosis presentations. Goravey W, Ali GA, Petkar M, Ammar A, Eldean MS, Al Maslamani MA, Abdel Hadi H. Clin Case Rep. 2020 Dec 5;9(2):714-717. doi: 10.1002/ccr3.3616. eCollection 2021 Feb. PMID: 33598231

  24. Primary cutaneous malignant melanoma in Rett syndrome: Report of a case with nuclear features resembling herpes simplex virus cytopathic effects-a hitherto unrecognized morphological variant. Petkar MA, Rodrigo T. J Cutan Pathol. 2021 Jul;48(7):908-910. doi: 10.1111/cup.13943. Epub 2021 Jan 24. PMID: 33345376

  25. Cardiac Amyloidosis Presenting with Pre-Excitation Syndrome, Heart Failure, and Severe Factor X Deficiency as Part of Systemic Amyloid Light-Chain (AL) Amyloidosis. Hussam Almasri , Ahmed Almeer , Samah Awouda , Omnia Hamid , Sundus Sardar , Zubair Anwer , Feryal Ibrahim , Dina Soliman , Yahya Kandathil , Mohammad Abu-Tineh , Imad Alabdul Razzak , Safaa Hasan Alazawi. .. Am J Case Rep. 2021 Aug 19;22:e933398. doi: 10.12659/AJCR.933398. PMID: 34413281; PMCID: PMC8382026.

  26. Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study. Najim M, Rahhal A, Khir F, Aljundi AH, Abu Yousef S, Ibrahim F, Amer A, Mohamed AS, Saleh S, Alfaridi D, Mahfouz A, Alyafei S, Howady F, Khatib M, Alemadi SA. Rheumatology International (2021) 41:1243–1252. PMID: 33954813 DOI: 10.1007/s00296-021-04875-7
  27. Coexistence of Prefibrotic Myelofibrosis with Monoclonal Gammopathy of Undetermined Significance: A Case Report. Omar M. Ismaila Aliaa Amer, Feryal A. Ibrahim, Mohammad Abu-Tineha Mohamed A. Yassina. Case Rep Oncol 2021;14:1435–1440. PMID: 34899233 PMCID: PMC8613572 DOI: 10.1159/000516746

  28. Biologic characterization of atypical chronic lymphocytic leukaemia. Soliman DS, Al-Kuwari E, Al-Abdulla R, Chandra P, Nashwan A, Hilmi FA. Biologic Int J Lab Hematol.. 2021 Jul 5. PMID: 34224207 DOI: 10.1111/ijlh.13645

  29. Aberrant Acquisition of T-cell Associated Markers in Plasma Cell Neoplasms: An Aggressive Disease with Extramedullary Involvement and Very Short Survival.Dina Sameh A. Soliman, Hesham El Sabah, Ibrahim Ganwo, Aliaa Amer, Ruba Y. Taha, Lajos Szabados, Mouhammad Sharaf Eldean, Ahmad Al-Sabbagh and Feryal Ibrahim. Mediterr J Hematol Infect Dis. 2021 Jul 1;13(1):e2021043. doi: 10.4084/MJHID.2021.043. PMID: 34276912; PMCID: PMC8265333.

  30. Downregulation of Lymphoid enhancer-binding factor 1(LEF-1) expression (by immunohistochemistry and/ flowcytometry) in chronic Lymphocytic Leukemia with atypical immunophenotypic and cytologic features. Dina S. Soliman, Einas Al-Kuwari, Kodappully S Siveen, Rajaa Al-Abdulla, Prem Chandra, Mohamed Yassin, Abdulqader Nashwan, Feryal A Hilmi, Ruba Y Taha, Zafar Nawaz, Halima El-Omri, Jericha M Mateo, Ahmad Al-Sabbagh. Int J Lab Hematol. 2021;43:515–525 PMID: 33314668 DOI: 10.1111/ijlh.13420

  31. P190BCR-ABL1 in a Patient with Philadelphia Chromosome Positive T-Cell Acute Lymphoblastic Leukemia: A Rare Case Report and Review of Literature. Samah Kohla, Sarah EL Kourashy, Zafar Nawaz, Reda Youssef, Ahmad Al-Sabbagh, Feryal A. Ibrahim. Case Rep Oncol. 2021 Jul 1;14(2):1040-1050. doi: 10.1159/000516270. PMID: 34326740; PMCID: PMC8299423.

  32. PD-L1 immunostaining: what pathologists need to know. Akhtar M, Rashid S, Al-Bozom IA. Diagn Pathol. 2021. PMID: 34689789

  33. Ciliated Cell Variant of Endometrial Carcinoma in an Adenomyoma in Uterus. Rashid S, et al. Cureus. 2021. PMID: 34354886

  34. Carcinomas of the Uterine Cervix: Comprehensive Review With An Update on Pathogenesis, Nomenclature of Precursor and Invasive Lesions, and Differential Diagnostic Considerations. Arafah M, Akhtar M, Rashid S. Adv Anat Pathol. 2021. PMID: 33825718

  35. Clinical outcomes, molecular epidemiology and resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa isolated from bloodstream infections from Qatar. Mazen A. Sid Ahmed, Jemal M. Hamid, Ahmed A. Husain, Hamad Abdel Hadi, Sini Skariah, Ali A. Sultan, Emad Bashir Ibrahim, Abdul Latif Al Khal, Bo Soderquist, Jana Jass & Ali S. Omrani (2021) Annals of Medicine, 53:1, 2345-2353, DOI: 10.1080/07853890.2021.2012588

  36. Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis. Atqah Abdul Wahab, Emad Ibrahim, Ali A. Sultan, Jana Jass, Mazen A. Sid Ahmed. European Respiratory Journal Sep 2021, 58 (suppl 65) PA2353; DOI: 10.1183/13993003.congress-2021.PA2353

  37. Well-Differentiated Liposarcoma of the Hypopharynx Exhibiting Myxoid Liposarcoma-like Morphology with MDM2 and DDIT3 Co-Amplification. Murshed KA, Abo Samra H, Ammar A.Head Neck Pathol. 2022 Mar;16(1):288-293. doi: 10.1007/s12105-021-01341-5. Epub 2021 Jun 4.PMID: 34089125

  38. Epidemiology of Multidrug-Resistant Pseudomonas aeruginosa in the Middle East and North Africa Region. Al-Orphaly M, Hadi HA, Eltayeb FK, Al-Hail H, Samuel BG, Sultan AA, Skariah S. mSphere. 2021 May 19;6(3):e00202-21. doi: 10.1128/mSphere.00202-21. PMID: 34011686; PMCID: PMC8265635.

  39. Minimal change nephrotic syndrome four days after the administration of Pfizer-BioNTech COVID-19 vaccine-a new side effect or coincidence? Abdulgayoom M, Albuni MK, Abdelmahmuod E, Murshed K, Eldeeb Y.Clin Case Rep. 2021 Oct 23;9(10):e05003. doi: 10.1002/ccr3.5003. eCollection 2021 Oct. PMID: 34721864

  40. Two SMARCAD1 Variants Causing Basan Syndrome in a Canadian and a Dutch Family. Elhaji Y, van Henten TMA, Ruivenkamp CAL, Nightingale M, Santen GW, Vos LE, Hull PR. JID Innov. 2021 May 6;1(3):100022. doi: 10.1016/j.xjidi.2021.100022. eCollection 2021 Sep. PMID: 34909722 Free PMC article.

  41. Clinicopathological Variables and Outcome in Chronic Myeloid Leukemia Associated With BCR-ABL1 Transcript Type and Body Weight: An Outcome of European LeukemiaNet Project. Abdulla MAJ, Chandra P, Akiki SE, Aldapt MB, Sardar S, Chapra A, Nashwan AJ, Sorio C, Tomasello L, Boni C, Yassin MA. Cancer Control. 2021 Jan- ec;28:10732748211038429. doi: 10.1177/10732748211038429. PMID: 34789006 Free PMC article.

  42. Effects of Intermittent Fasting on Response to Tyrosine Kinase Inhibitors (TKIs) in Patients With Chronic Myeloid Leukemia: An Outcome of European LeukemiaNet Project. Yassin MA, Ghasoub RS, Aldapt MB, Abdulla MA, Chandra P, Shwaylia HM, Nashwan AJ, Kassem NA, Akiki SJ.Cancer Control. 2021 Jan- ec;28:10732748211009256.doi:10.1177/10732748211009256. PMID: 33874754 Free PMC article.

  43. A Case Report of BCR-ABL-JAK2-Positive Chronic Myeloid Leukemia with Complete Hematological and Major Molecular Response to Dasatinib. Ali EAH, Al-Akiki S, Yassin MA. Case Rep Oncol. 2021 Apr 15;14(1):690-694. doi: 10.1159/000514632. eCollection 2021 Jan-Apr. PMID: 34054462 Free PMC article. 

  44. High-Grade Epstein-Barr Virus-Negative Biphenotypic Lymphoma with Expression of B- and T-Cell Markers and Leukemia Presentation: Case Report and Literature Review. Kohla S, Ibrahim FA, Mudawi D, Akiki S, Soliman D, Al-Sabbagh A, Youssef RRH, Yassin MA. Case Rep Oncol. 2020 Sep 30;13(3):1215-1226. doi: 10.1159/000510403. eCollection 2020 Sep-Dec.PMID: 33173488 Free PMC article

  45. Actionable genomic variants in 6045 participants from the Qatar Genome Program. Elfatih A, Mifsud B, Syed N, Badii R, Mbarek H, Abbaszadeh F; Qatar Genome Program Research Consortium, Estivill X.Hum Mutat. 2021 Aug 24. doi: 10.1002/humu.24278. Online ahead of print.PMID: 34428338